InvestorsHub Logo
Followers 46
Posts 5239
Boards Moderated 0
Alias Born 01/27/2012

Re: xodcode post# 412765

Friday, 04/28/2023 11:35:46 AM

Friday, April 28, 2023 11:35:46 AM

Post# of 463347
I caught that too XO. I feel more and more that Dr. Missling is going down a conventional trial process in an unconventional way to gain approval. Stated another way imo Dr. Missling is using an antiquated trial process (who a few here split hairs to infinity and beyond) to prove that our drug is a prophylactic drug, not a one trick pony drug for Alzheimer’s or Rett Syndrome etc. His repeated reference to the path that cancer treatment took whereby science use to focus on treating the symptoms only (paraphrasing) instead of working symbiotically with the body to help fight the problem has me believing we are light years ahead of the world in the advancement of disease treatment. Slowly one trial at a time, one data set at a time, very methodically he is building a new data set thus creating/testing a new trial criteria for judging successful symptomatic relief/efficacy of a drug and in a much more sensitive/well defined way taking into account ways to prove ALL the anecdotal benefits we are seeing.

To steal McMagyar’s line “Blarcasamine, the human health drug!”

When Dr. Missling repeatedly says nearing commercialization coupled with the new hires and recent restructuring on the BOD I get the feeling we are in for some very positive, near term, rapid growth changes.

Cheers
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News